Jun 10, 2022 | Edinburgh BioQuarter, Edinburgh Technopole, Member News
RoslinCT – a cell and gene therapy/ATMP CDMO, developing life-changing cell and gene therapies in Edinburgh’s BioQuarter– signs lease for 1,453 sqm additional space at Charles Darwin House at the Edinburgh Technopole. The additional space will include fully...
May 20, 2022 | Edinburgh BioQuarter, Member News
A new multi-million pound research programme to develop treatments for lung infections such as Covid-19 and future pandemics has been announced at the University of Edinburgh with support from a significant donation by Baillie Gifford. The Baillie Gifford Pandemic...
Jan 20, 2022 | Edinburgh BioQuarter, Member News
RoslinCT, a leading Contract Development and Manufacturing Organization (CDMO) focused on advanced cell therapies, announces investment from Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare....
Nov 3, 2021 | Edinburgh BioQuarter
Edinburgh BioQuarter has formally launched its public procurement process for a private sector partner. The opportunity to create a £1billion (estimated gross development value) health innovation district which will create jobs, homes, and a community for thousands of...
Aug 26, 2021 | Edinburgh BioQuarter, Member News
Progress innovation in a collaborative ecosystem Webinar 13:00-14:00 BST, 31 August 2021 Hosted jointly by Edinburgh BioQuarter and Edinburgh Innovations, the webinar will explore how new medical treatments are progressed from bench to bedside at BioQuarter, and the...
Jun 29, 2021 | Edinburgh BioQuarter, Member News
The Cell and Gene Therapy Catapult (CGT Catapult) announces that it will establish offices and laboratories in Edinburgh, on Edinburgh BioQuarter. With this expansion CGT Catapult aims to provide additional regionally focussed support to the cell and gene therapy...
